TLR2 and breast cancer: The breast cancer exosomes induce the activation of NF-κB and the overexpression of IL-6, TNFα, GCSF, and CCL2 in macrophages located in the brain and lung through the binding of Toll-like receptor 2 (TLR2) or MyD88 (54).